MétaCan
Menu
Back to cohort
Record W4386195357 · doi:10.1101/2023.08.24.23294503

Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults

2023· preprint· en· W4386195357 on OpenAlexafffundabout
Nelson Lee, Lena Nguyen, Peter C. Austin, Kevin A. Brown, Ramandip Grewal, Sarah A. Buchan, Sharifa Nasreen, Jonathan B. Gubbay, Kevin L. Schwartz, Mina Tadrous, Kumanan Wilson, Sarah E. Wilson, Jeffrey C. Kwong

Bibliographic record

VenuemedRxiv · 2023
Typepreprint
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsBruyèreOttawa HospitalUniversity of OttawaInstitute for Clinical Evaluative SciencesWomen's College HospitalUniversity Health NetworkUniversity of TorontoBC Children's HospitalPublic Health Ontario
FundersDepartment of Family and Community Medicine, University of TorontoCanadian Institutes of Health ResearchCanadian Immunization Research NetworkUniversity of TorontoPublic Health AgencyPublic Health Agency of Canada
KeywordsMedicineVaccinationCoronavirus disease 2019 (COVID-19)Logistic regressionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunityOdds ratioInternal medicineImmunologyImmune system

Abstract

fetched live from OpenAlex

Abstract Introduction We assessed protection conferred by COVID-19 vaccines and/or prior SARS-CoV-2 infection against Omicron-associated severe outcomes during successive sublineage-predominant periods. Methods We used a test-negative design to estimate protection by vaccines and/or prior infection against hospitalization/death among community-dwelling, PCR-tested adults aged ≥50 years in Ontario, Canada between January 2, 2022 and June 30, 2023. Multivariable logistic regression was used to estimate the relative change in the odds of hospitalization/death with each vaccine dose (2−5) and/or prior PCR-confirmed SARS-CoV-2 infection (compared with unvaccinated, uninfected subjects) up to 15 months since the last vaccination or infection. Results We included 18,526 cases with Omicron-associated severe outcomes and 90,778 test-negative controls. Vaccine protection was high during BA.1/BA.2 predominance, but was generally <50% during periods of BA.4/BA.5 and BQ/XBB predominance without boosters. A third/fourth dose transiently increased protection during BA.4/BA.5 predominance ( third-dose, 6-month: 68%, 95%CI 63%−72%; fourth-dose, 6-month: 80%, 95%CI 77%−83%), but was lower and waned quickly during BQ/XBB predominance ( third-dose, 6-month: 59%, 95%CI 48%−67%; 12-month: 49%, 95%CI 41%−56%; fourth-dose, 6-month: 62%, 95%CI 56%−68%, 12-months: 51%, 95%CI 41%−56%). Hybrid immunity conferred nearly 90% protection throughout BA.1/BA.2 and BA.4/BA.5 predominance, but was reduced during BQ/XBB predominance ( third-dose, 6-month: 60%, 95%CI 36%−75%; fourth-dose, 6-month: 63%, 95%CI 42%−76%). Protection was restored with a fifth dose (bivalent; 6-month: 91%, 95%CI 79%−96%). Prior infection alone did not confer lasting protection. Conclusion Protection from COVID-19 vaccines and/or prior SARS-CoV-2 infections against severe outcomes is reduced when immune-evasive variants/subvariants emerge and may also wane over time. Our findings support a variant-adapted booster vaccination strategy with periodic review.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.089
Threshold uncertainty score0.178

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.096
GPT teacher head0.369
Teacher spread0.274 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2023
Admission routes3
Has abstractyes

Explore more

Same venuemedRxivSame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207